These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 30175528)

  • 21. Treadmill exercise and methylphenidate ameliorate symptoms of attention deficit/hyperactivity disorder through enhancing dopamine synthesis and brain-derived neurotrophic factor expression in spontaneous hypertensive rats.
    Kim H; Heo HI; Kim DH; Ko IG; Lee SS; Kim SE; Kim BK; Kim TW; Ji ES; Kim JD; Shin MS; Choi YW; Kim CJ
    Neurosci Lett; 2011 Oct; 504(1):35-9. PubMed ID: 21907264
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dopamine transporter gene and response to methylphenidate in attention-deficit/hyperactivity disorder.
    Roman T; Szobot C; Martins S; Biederman J; Rohde LA; Hutz MH
    Pharmacogenetics; 2002 Aug; 12(6):497-9. PubMed ID: 12172219
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chronic oral methylphenidate treatment reversibly increases striatal dopamine transporter and dopamine type 1 receptor binding in rats.
    Robison LS; Ananth M; Hadjiargyrou M; Komatsu DE; Thanos PK
    J Neural Transm (Vienna); 2017 May; 124(5):655-667. PubMed ID: 28116523
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Perseveration by NK1R-/- ('knockout') mice is blunted by doses of methylphenidate that affect neither other aspects of their cognitive performance nor the behaviour of wild-type mice in the 5-Choice Continuous Performance Test.
    Pillidge K; Porter AJ; Young JW; Stanford SC
    J Psychopharmacol; 2016 Sep; 30(9):837-47. PubMed ID: 27097734
    [TBL] [Abstract][Full Text] [Related]  

  • 25. How stimulant drugs may calm hyperactivity.
    Marx J
    Science; 1999 Jan; 283(5400):306. PubMed ID: 9925481
    [No Abstract]   [Full Text] [Related]  

  • 26. Methylphenidate treatment in adolescent rats with an attention deficit/hyperactivity disorder phenotype: cocaine addiction vulnerability and dopamine transporter function.
    Harvey RC; Sen S; Deaciuc A; Dwoskin LP; Kantak KM
    Neuropsychopharmacology; 2011 Mar; 36(4):837-47. PubMed ID: 21150910
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential behavioral and neurochemical effects of cocaine after early exposure to methylphenidate in an animal model of attention deficit hyperactivity disorder.
    Augustyniak PN; Kourrich S; Rezazadeh SM; Stewart J; Arvanitogiannis A
    Behav Brain Res; 2006 Feb; 167(2):379-82. PubMed ID: 16246436
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential psychostimulant-induced activation of neural circuits in dopamine transporter knockout and wild type mice.
    Trinh JV; Nehrenberg DL; Jacobsen JP; Caron MG; Wetsel WC
    Neuroscience; 2003; 118(2):297-310. PubMed ID: 12699766
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acute effects of methylphenidate on impulsivity and attentional behavior among adolescents comorbid for ADHD and conduct disorder.
    Dougherty DM; Olvera RL; Acheson A; Hill-Kapturczak N; Ryan SR; Mathias CW
    J Adolesc; 2016 Dec; 53():222-230. PubMed ID: 27816696
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of chronic methylphenidate administration on presynaptic dopaminergic parameters in a rat model for ADHD.
    Simchon Y; Weizman A; Rehavi M
    Eur Neuropsychopharmacol; 2010 Oct; 20(10):714-20. PubMed ID: 20493667
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacogenetics of response to methylphenidate in adult patients with Attention-Deficit/Hyperactivity Disorder (ADHD): a systematic review.
    Contini V; Rovaris DL; Victor MM; Grevet EH; Rohde LA; Bau CH
    Eur Neuropsychopharmacol; 2013 Jun; 23(6):555-60. PubMed ID: 22709890
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of the 480 bp DAT1 allele with methylphenidate response in a sample of Irish children with ADHD.
    Kirley A; Lowe N; Hawi Z; Mullins C; Daly G; Waldman I; McCarron M; O'Donnell D; Fitzgerald M; Gill M
    Am J Med Genet B Neuropsychiatr Genet; 2003 Aug; 121B(1):50-4. PubMed ID: 12898575
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impaired cliff avoidance reaction in dopamine transporter knockout mice.
    Yamashita M; Sakakibara Y; Hall FS; Numachi Y; Yoshida S; Kobayashi H; Uchiumi O; Uhl GR; Kasahara Y; Sora I
    Psychopharmacology (Berl); 2013 Jun; 227(4):741-9. PubMed ID: 23397052
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reward modulation of cognitive function in adult attention-deficit/hyperactivity disorder: a pilot study on the role of striatal dopamine.
    Aarts E; van Holstein M; Hoogman M; Onnink M; Kan C; Franke B; Buitelaar J; Cools R
    Behav Pharmacol; 2015 Feb; 26(1-2):227-40. PubMed ID: 25485641
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term stimulant treatment affects brain dopamine transporter level in patients with attention deficit hyperactive disorder.
    Wang GJ; Volkow ND; Wigal T; Kollins SH; Newcorn JH; Telang F; Logan J; Jayne M; Wong CT; Han H; Fowler JS; Zhu W; Swanson JM
    PLoS One; 2013; 8(5):e63023. PubMed ID: 23696790
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of clonidine and methylphenidate on motor activity in Fmr1 knockout mice.
    Wrenn CC; Heitzer AM; Roth AK; Nawrocki L; Valdovinos MG
    Neurosci Lett; 2015 Jan; 585():109-13. PubMed ID: 25433180
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alterations in pain response are partially reversed by methylphenidate (Ritalin) in adults with attention deficit hyperactivity disorder (ADHD).
    Treister R; Eisenberg E; Demeter N; Pud D
    Pain Pract; 2015 Jan; 15(1):4-11. PubMed ID: 24134430
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lack of Cdk5 activity is involved on Dopamine Transporter expression and function: Evidences from an animal model of Attention-Deficit Hyperactivity Disorder.
    Fernández G; Krapacher F; Ferreras S; Quassollo G; Mari MM; Pisano MV; Montemerlo A; Rubianes MD; Bregonzio C; Arias C; Paglini MG
    Exp Neurol; 2021 Dec; 346():113866. PubMed ID: 34537209
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serotonin and the therapeutic effects of ritalin.
    Volkow ND; Gatley SJ; Fowler JS; Wang GJ; Swanson J
    Science; 2000 Apr; 288(5463):11. PubMed ID: 10766624
    [No Abstract]   [Full Text] [Related]  

  • 40. Attention-Deficit/Hyperactivity Disorder-like Phenotype in a Mouse Model with Impaired Actin Dynamics.
    Zimmermann AM; Jene T; Wolf M; Görlich A; Gurniak CB; Sassoè-Pognetto M; Witke W; Friauf E; Rust MB
    Biol Psychiatry; 2015 Jul; 78(2):95-106. PubMed ID: 24768258
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.